Vishal Mega Mart Limited (NSE:VMM)
India · Delayed Price · Currency is INR 140.84
-0.23 (-0.16%)
Last updated: Aug 4, 2025
Verve Therapeutics Revenue
In the fiscal year ending March 31, 2025, Vishal Mega Mart had annual revenue of 107.16B INR with 20.25% growth. Vishal Mega Mart had revenue of 25.48B in the quarter ending March 31, 2025, with 23.15% growth.
Revenue
107.16B
Revenue Growth
+20.25%
P/S Ratio
6.14
Revenue / Employee
6.48M
Employees
16,537
Market Cap
657.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 107.16B | 18.04B | 20.25% |
| Mar 31, 2024 | 89.12B | 13.26B | 17.48% |
| Mar 31, 2023 | 75.86B | 19.98B | 35.74% |
| Mar 31, 2022 | 55.89B | 11.36B | 25.52% |
| Mar 31, 2021 | 44.52B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maruti Suzuki India | 1,557.39B |
| Mahindra & Mahindra | 1,696.86B |
| Eternal | 232.04B |
| Hyundai Motor India | 682.62B |
| Swiggy | 169.65B |
| MRF Limited | 281.71B |
| Kalyan Jewellers India | 250.45B |
| FSN E-Commerce Ventures | 79.50B |